Immune-Related Adverse Events

Real-World Study Evaluates Outcomes With Ipilimumab and Nivolumab in MesotheliomaПодробнее

Genetic risk factors for checkpoint inhibitor-related endocrine toxicitiesПодробнее

The future of antibody-drug conjugates in urothelial carcinomaПодробнее

Managing immune-related adverse events in adjuvant immunotherapyПодробнее

Enhancing ICI outcomes of patients with NSCLC from underserved communitiesПодробнее

AUA SIU Symposium Therapeutic Advances In Immuno - OncologyПодробнее

Peer-Reviewed Guidance on How to Manage Immune-Related Adverse Events & ToxicitiesПодробнее

GU Podcast (2020): Immune Checkpoint Inhibitors In RCCПодробнее

Understanding Nivolumab: A Guide for Patients on ImmunotherapyПодробнее

Advances in Immunotherapy: Expert Nursing Insights on IRAE ManagementПодробнее

From rashes to heart issues, ICIs can have surprising side effects. We're breaking them down.Подробнее

Managing Thyroid Adverse Events From Checkpoint InhibitorsПодробнее

SOT Weekly Update 7-25-2024Подробнее

Abstract Presentation by Lily May Lau on Renal Cell Autoimmune EncephalitisПодробнее

Additional Advances in Immune-Related Adverse Events Research and Trials With Beth Sandy, MSN, CRNPПодробнее

Dr Hajj Chehade on Potential Risk Factors for irAE Development in mRCCПодробнее

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by ... | RTCL.TVПодробнее

Dr Saad on the Association Between IL-7 SNPs and Immune-Related AEs in RCCПодробнее

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by ... | RTCL.TVПодробнее